Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
暂无分享,去创建一个
E. Koritáková | H. Klamová | E. Faber | P. Žák | J. Mayer | Z. Ráčil | T. Sacha | D. Réa | J. Procházková | D. Zackova | P. Cetkovský | P. Belohlavkova | J. Voglová | J. Wącław | L. Malášková